a public good project by the
Synthesis
Company
of California

© 2026

Reinhard Seger | doi.page

0 works0 citations0 h-index

Reinhard Seger

Publications by Year

Research Areas

Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Immunodeficiency and Autoimmune Disorders, Blood disorders and treatments, Virus-based gene therapy research, Antifungal resistance and susceptibility

Most-Cited Works

→ Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1(2006)1,183 cited
→ Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis(2011)792 cited
→ Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease(2010)775 cited
→ Chronic Granulomatous Disease: The European Experience(2009)678 cited
→ The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity(2019)600 cited
→ Restoration of NET formation by gene therapy in CGD controls aspergillosis(2009)576 cited

→ Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99(2003)

573 cited

→ Primary immunodeficiency diseases: An update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee(2007)559 cited

→ RAG Mutations in Human B Cell-Negative SCID(1996)531 cited

→ Griscelli disease maps to chromosome 15q21 and is associated with mutations in the Myosin-Va gene(1997)456 cited